arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Orchestra BioMed Holdings, Inc.

OBIO

$4.22 ▲ +0.06 (+1.44%) at close

24 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Orchestra BioMed Holdings, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $264.7M

Dividend Yield —

Revenue Growth -87.3% ↘

Op. Margin None

ROIC -116.3% ↘

FCF / Share $-0.36

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

24-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$110.00K

↓ -87.3% —

Net Income Profit after all expenses

$-20.69M

↓ -10.3% —

FCF / Share Free cash flow per share

$-0.36

↑ +18.5% —

Long-Term Debt Long-term obligations

$15.00M

— 0.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Revenue Growth YoY (%)	-87.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1192%)	12120.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+151402%)	-12.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-260%)	7.5% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-7%)	40.0% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+400%)	-3.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-143%)	135.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1595%)	-15.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-287%)	-46.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-684%)	-76.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1053%)	-64.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-900%)	128.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1502%)	34.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+330%)	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	32.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	2.4% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-11.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-28.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-16.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-7.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-28.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	5.0% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	15.9% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	25.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	54.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	35.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-4300.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-10.3% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-39.3% Weak ↓ Weak Declining Year-over-year change in net income	-39.3% Weak ↓ Weak Declining Year-over-year change in net income	-39.3% Weak ↓ Weak Declining Year-over-year change in net income	-26.0% Weak ↓ Weak Declining Year-over-year change in net income	-23.1% Weak ↑ Weak Improving Year-over-year change in net income	-23.1% Weak ↑ Weak Improving Year-over-year change in net income	-23.1% Weak ↑ Weak Improving Year-over-year change in net income	-31.5% Weak ↑ Weak Improving Year-over-year change in net income	-91.0% Weak ↑ Weak Improving Year-over-year change in net income	-91.0% Weak ↑ Weak Improving Year-over-year change in net income	-91.0% Weak ↑ Weak Improving Year-over-year change in net income	-10978.2% Weak ↓ Weak Declining Year-over-year change in net income	-6236.6% Weak ↓ Weak Declining Year-over-year change in net income	-6105.0% Weak ↓ Weak Declining Year-over-year change in net income	-5204.5% Weak ↓ Weak Declining Year-over-year change in net income	—	-11.0% Weak Weak Year-over-year change in net income	-506.8% Weak Weak Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	18.5% Good Good Year-over-year change in free cash flow	—	—	—	-19.3% Weak Weak Year-over-year change in free cash flow	—	—	—	29.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	10.4% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-54.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	203.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-9.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	27.7% Excellent Excellent Compound annual revenue growth over 3 years	0.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Operating Margin (%) (%)	—	21.8% Good Good Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+46%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	20.2% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+68%)	—	—	—	—	—	—	—	—	—	—	—	—	-492.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4205%)	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	-7.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.32x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.44x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	3.04x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Return on Invested Capital (%)	-116.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	35.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-107.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-101.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-99.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	-114.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-102.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-5193.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	1.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-1.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-88.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%
Return on Capital (%) (%)	-21.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	5.9% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-19.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-0.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-0.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-11.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	—	—	—	—	2.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	2.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	-1.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-112%)	-2.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-114%)	—	-1.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	-112.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-849%)

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	-30.97x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-28.35x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-32.89x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-23.40x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-26.01x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-29.70x Weak Weak Operating income divided by interest expense Optimal: > 5x	-21.73x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-13.37M	$-19.69M	$-27.01M	$-3.75M	$-3.35M	$-22.26M	$-25.61M	$-23.71M	$-23.32M	$-30.56M	$-9.08M	$-6.41M	$-18.70M	$-19.78M	—	—	—	$-1.75M	$-1.78M	$-1.91M	$-1.95M	$-2.03M	$-2.04M	$-193.69K
Debt / EBITDA (x)	-0.68x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.19x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.74x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.78x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.80x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	-0.69x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.78x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Revenue per Share (USD)	$0.00	—	$0.02	$0.02	$0.02	—	$0.03	$0.02	$0.02	—	$0.01	$0.03	$0.04	—	$0.06	$0.04	$0.09	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.33	$0.26	$-0.40	$-0.50	$-0.49	$-0.43	$-0.41	$-0.45	$-0.38	$-0.37	$-0.38	$-0.35	$-0.40	$-0.44	$-0.51	$-0.77	$-0.62	$-0.01	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.36	—	$-0.28	$-0.41	$-0.44	—	—	—	$-0.37	—	—	—	$-0.52	—	$-0.37	$-0.81	$-0.58	—	—	—	—	—	—	—
Book Value per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$3.14	—	—	—	$0.01	$-0.89	$-0.87	$0.94	$0.94	$-0.80	$0.94	—
Tangible Book Value per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$3.14	—	—	—	$0.01	$-0.89	$-0.87	$0.94	$0.94	$-0.80	$0.94	—
Basic Weighted Avg Shares (shares)	62.72M	—	52.19M	38.39M	38.24M	—	37.62M	35.80M	35.78M	—	35.24M	34.61M	27.64M	—	20.19M	10.14M	9.23M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Working Capital (USD)	$82.52M	$91.17M	$77.11M	$18.82M	$36.41M	$52.96M	$52.34M	$51.98M	$66.01M	$77.91M	$88.72M	$107.73M	$117.82M	$66.12M	—	—	—	$1.64M	$1.73M	$1.82M	$1.92M	$2.03M	$2.13M	—
LT Debt (USD)	$15.00M	$15.00M	$15.00M	$15.00M	$15.00M	—	—	—	—	—	$10.00M	$10.00M	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$99.75M	—	—	—	$78.00K	$-3.94M	$-3.85M	$5.00M	$5.00M	$-3.56M	$5.00M	$13.54K

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Sales/Revenue/Turnover (USD)	$110.00K	$30.92M	$861.00K	$836.00K	$868.00K	$253.00K	$987.00K	$778.00K	$620.00K	$262.00K	$419.00K	$915.00K	$1.16M	$1.10M	$1.16M	$401.00K	$866.00K	—	—	—	—	—	—	—
Depreciation Expense (USD)	$90.00K	$82.00K	$81.00K	$81.00K	$83.00K	$84.00K	$76.00K	$74.00K	$74.00K	$72.00K	$71.00K	$72.00K	$71.00K	$70.00K	$54.00K	$50.00K	$48.00K	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-20.69M	$6.25M	$-18.75M	$-18.75M	$-18.75M	$-16.16M	$-13.46M	$-13.46M	$-13.46M	$-12.82M	$-10.94M	$-10.94M	$-10.94M	$-9.75M	$-5.73M	$-5.73M	$-5.73M	$-88.01K	$-90.41K	$-92.33K	$-108.00K	—	$-81.43K	$-15.21K
Operating Cash Flow (USD)	$-22.17M	$-2.27M	$-14.55M	$-15.53M	$-16.62M	$-13.54M	—	—	$-13.11M	$-10.97M	—	—	$-14.38M	$-8.74M	$-7.26M	$-7.96M	$-5.32M	$-28.84K	—	—	$-76.37K	—	$-247.52K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 24 quarters

Orchestra BioMed Holdings, Inc.

Analytical Summary

24-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare OBIO with peers